{"title": "Tratamientos para el COVID-19", "author": null, "url": "https://www.publichealthwm.org/covid-19/recursos-espanol/Tratamientos", "hostname": "publichealthwm.org", "description": null, "sitename": "publichealthwm.org", "date": "2023-01-01", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "La mayor\u00eda de la informaci\u00f3n que est\u00e1 a continuaci\u00f3n se tom\u00f3 de\n[mass.gov](http://www.mass.gov/info-details/treatments-for-covid-19) y de [los CDC](http://www.cdc.gov/coronavirus/2019-ncov/your-health/treatments-for-severe-illness.html). Visite sus sitios web para obtener m\u00e1s informaci\u00f3n. [Elegibilidad](#Elegibilidad) [Tipos de tratamientos](#Tipos) [C\u00f3mo acceder a los tratamientos](#Acceder) [Programa de prueba y tratamiento](#Programa) [Preguntas frecuentes](#)\nELEGIBILIDAD [Los tratamientos terap\u00e9uticos](https://www.mass.gov/info-details/treatments-for-covid-19) para el COVID-19, que incluyen anticuerpos monoclonales y antivirales, pueden ayudar a reducir la cantidad de virus en el cuerpo y protegerlo de los s\u00edntomas graves. Pueden ayudar a prevenir la hospitalizaci\u00f3n y reducir el riesgo de enfermedad grave.\nHay tratamientos gratis disponibles para las personas que cumplan todos los requisitos que siguen a continuaci\u00f3n:\n- tienen\n[mayor riesgo de enfermedad grave](http://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html)(tiene un solo factor de riesgo) o m\u00e1s de 65 a\u00f1os, y\n- tienen un resultado positivo de COVID-19 (en una prueba casera o PCR) y\n- tienen\n[cualquier s\u00edntoma](http://www.mass.gov/info-details/about-covid-19-symptoms-and-spread), incluso leve (como goteo nasal o tos).\nTIPOS DE TRATAMIENTOS\nMedicamentos orales antivirales:\n- Paxlovid\n- Debe tomarse dentro de los 5 d\u00edas de su primer s\u00edntoma de COVID-19\n- Debe tener 12 a\u00f1os o m\u00e1s y pesar al menos 88 libras\n- Las interacciones con muchos medicamentos y suplementos/vitaminas, incluidos los comunes que se venden sin receta, pueden causar complicaciones graves, por lo que es importante que los proveedores de atenci\u00f3n m\u00e9dica tengan una lista actualizada de medicamentos y suplementos antes de recetarlos.\n- Molnupiravir\n- Debe tomarse dentro de los 5 d\u00edas de su primer s\u00edntoma de COVID-19\n- Debe tener 18 a\u00f1os o m\u00e1s\n- El CDC recomienda que este medicamento se use cuando no hay otros tratamientos disponibles.\nInyecciones intravenosas:\n- Remdesivir (nombre de marca Velurky)\n- Dado durante 3 d\u00edas consecutivos\n- Debe administrarse dentro de los 7 d\u00edas posteriores a su primer s\u00edntoma de COVID-19\n- Disponible para ni\u00f1os y adultos. Los ni\u00f1os son elegibles si tienen: 28 d\u00edas o m\u00e1s, pesan al menos 7 libras, dan positivo en la prueba de COVID y tienen un alto riesgo de enfermedad grave son elegibles\nObtenga m\u00e1s informaci\u00f3n sobre los tratamientos aprobados de\n[Yale Medicine](http://www.yalemedicine.org/news/covid-19-treatment-drugs) (mayo de 2023).\nC\u00d3MO ACCEDER A LOS TRATAMIENTOS\nLos tratamientos son GRATIS y no se requiere seguro. Hay varias formas de acceder a los tratamientos:\n1) Llame a su m\u00e9dico de inmediato para conocer sus opciones de tratamiento.\n2)\n[Telesalud](https://www.mass.gov/info-details/free-telehealth-for-covid-19-treatment-with-paxlovid)\n- Los residentes de MA pueden ser evaluados directamente para el tratamiento de COVID-19, sin comunicarse con su proveedor de atenci\u00f3n m\u00e9dica\n- Solicite una consulta gratuita de telesalud en\n[l\u00ednea](https://www.mass.gov/info-details/free-telehealth-for-covid-19-treatment-with-paxlovid#get-a-free-telehealth-consultation-)o llamando al [833-273-6330](tel:833-273-6330)\n- Los m\u00e9dicos est\u00e1n disponibles todos los d\u00edas de 8 am a 10 pm.\n- El servicio de telesalud se ofrece en colaboraci\u00f3n con\n[Color Health, Inc.](https://www.color.com/)\n3)\n[Programa de tratamiento en el hogar](https://www.mass.gov/info-details/in-home-covid-19-treatment-program)\n- El tratamiento con Remdesivir en el hogar est\u00e1 disponible para cualquier persona que cumpla con los criterios cl\u00ednicos y tenga dificultades para acceder a \u00e9l en la comunidad.\n- Los pacientes y sus proveedores de atenci\u00f3n m\u00e9dica pueden llamar al Centro de llamadas de tratamiento de COVID-19 en el hogar de CDR Health al\n[617-644-7592](tel:617-644-7592)de lunes a s\u00e1bado de 8 am a 6 pm. Las citas tambi\u00e9n se pueden programar directamente en la p\u00e1gina del Portal del paciente de CDR Health en [patientportalma.com](https://www.patientportalma.com/s/?language=en_US).\n4)\n[Herramienta de localizaci\u00f3n de MA Therapeutics](https://www.mass.gov/info-details/information-for-providers-about-therapeutic-treatments-for-covid-19#covid-19-therapeutic-locator-)\n- Busque tratamientos espec\u00edficos y las ubicaciones m\u00e1s cercanas cerca de usted.\n- Tambi\u00e9n puede llamar al\n[800-232-0233](tel:800-232-0233)(TTY [888-720-7489](tel:888-720-7489)) para obtener ayuda en ingl\u00e9s, espa\u00f1ol y m\u00e1s de 150 idiomas m\u00e1s.\nPROGRAMA DE PRUEBA Y TRATAMIENTO\nLa administraci\u00f3n de Biden lanz\u00f3 una nueva iniciativa Prueba y Tratamiento (Test to Treat) a nivel nacional en marzo de 2022 para brindarles a las personas un acceso r\u00e1pido a los tratamientos m\u00e9dicos gratuitos para el COVID-19. A trav\u00e9s de este programa, las personas se pueden hacer una prueba y \u2014si tienen un resultado positivo y los tratamientos son adecuados para ellas\u2014 recibir\u00e1n una receta de un proveedor de atenci\u00f3n m\u00e9dica y les surtir\u00e1n el medicamento en el mismo lugar. Estos lugares\ndenominados \u201cOne-Stop Test to Treat\u201d est\u00e1n disponibles en cientos de ubicaciones en todo el pa\u00eds, lo que incluye cl\u00ednicas de farmacias, centros de salud federales y centros de cuidados a largo plazo.\n[Obtenga m\u00e1s informaci\u00f3n](https://aspr.hhs.gov/TestToTreat/Pages/default.aspx) y [encuentre una ubicaci\u00f3n de prueba y tratamiento de uste](https://covid-19-test-to-treat-locator-dhhs.hub.arcgis.com/) [d](http://covid-19-test-to-treat-locator-dhhs.hub.arcgis.com/).\nPREGUNTAS FRECUENTES\nSi el COVID-19 se puede tratar, \u00bfigual me tengo que vacunar?\nS\u00ed. Prevenir el COVID-19 es m\u00e1s eficaz que tratarlo. Las vacunas protegen a las personas de infectarse o de enfermarse de gravedad, y las mascarillas y el distanciamiento f\u00edsico ayudan a evitar que el virus se propague.\n\u00bfSon los tratamientos seguros y efectivos?\n- Paxlovid: La FDA emiti\u00f3 la autorizaci\u00f3n completa para adultos en diciembre de 2023 y contin\u00faa teniendo la Autorizaci\u00f3n de uso de emergencia (EUA) para ni\u00f1os de 12 a\u00f1os en adelante. En un ensayo cl\u00ednico, Paxlovid redujo el riesgo de hospitalizaci\u00f3n y muerte en un 86% en pacientes ambulatorios no vacunados con COVID-19 con mayor riesgo de enfermedad grave. Los eventos adversos graves son poco frecuentes con el tratamiento con Paxlovid.\n- Remdesivir (Veklury): est\u00e1 aprobado por la FDA. Originalmente fue autorizado por la FDA para tratar a pacientes hospitalizados con neumon\u00eda por COVID, ahora se usa fuera de etiqueta para el tratamiento de pacientes ambulatorios. Remdesivir redujo el riesgo de hospitalizaci\u00f3n y muerte en un 87 % en pacientes ambulatorios no vacunados con COVID-19 con mayor riesgo de enfermedad grave.\n- Molnupiravir: tiene autorizaci\u00f3n de uso de emergencia (EUA) emitida por la FDA. Un antiviral oral que tiene datos de eficacia marginales y preocupaciones de seguridad con respecto a la toxicidad reproductiva. Primero se recomiendan otros tratamientos.", "language": null, "image": null, "pagetype": null, "links": ["http://enable-javascript.com/", "#page-content", "https://www.publichealthwm.org/", "https://www.publichealthwm.org/what-health-equity", "https://www.publichealthwm.org/what-health-equity/what-influences-health", "https://www.publichealthwm.org/what-health-equity/racial-equity-resources", "https://www.publichealthwm.org/what-health-equity/june-14th-health-equity-event", "https://www.publichealthwm.org/who-we-are", "https://www.publichealthwm.org/who-we-are/mission", "https://www.publichealthwm.org/who-we-are/board", "https://www.publichealthwm.org/who-we-are/staff", "https://www.publichealthwm.org/who-we-are/impact", "https://www.publichealthwm.org/who-we-are/history", "https://www.publichealthwm.org/who-we-are/join-our-team", "https://www.publichealthwm.org/what-we-do", "https://www.publichealthwm.org/what-we-do/coalition-building", "https://www.publichealthwm.org/what-we-do/research-evaluation", "https://www.publichealthwm.org/policy", "https://www.publichealthwm.org/what-we-do/data-reports", "https://www.publichealthwm.org/news-events", "https://www.publichealthwm.org/contact-us", "https://www.publichealthwm.org/covid-19", "https://www.publichealthwm.org/covid-19/data", "https://www.publichealthwm.org/covid-19/prevention", "https://www.publichealthwm.org/covid-19/Testing-Resources", "https://www.publichealthwm.org/covid-19/vaccine", "https://www.publichealthwm.org/covid-19/Treatments", "https://www.publichealthwm.org/covid-19/covid-19-community-resources", "https://www.publichealthwm.org/covid-19/recursos-espanol", "https://www.publichealthwm.org/covid-19/events", "https://www.publichealthwm.org/covid-19/advocacy", "#site-search", "#mobile-menu", "javascript:window.print();", "https://www.publichealthwm.org/", "https://www.publichealthwm.org/covid-19", "https://www.publichealthwm.org/covid-19/recursos-espanol", "http://www.mass.gov/info-details/treatments-for-covid-19", "http://www.cdc.gov/coronavirus/2019-ncov/your-health/treatments-for-severe-illness.html", "#Elegibilidad", "#Tipos", "#Acceder", "#Programa", "#", null, "https://www.mass.gov/info-details/treatments-for-covid-19", "http://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html", "http://www.mass.gov/info-details/about-covid-19-symptoms-and-spread", null, "http://www.yalemedicine.org/news/covid-19-treatment-drugs", null, "https://www.mass.gov/info-details/free-telehealth-for-covid-19-treatment-with-paxlovid", "https://www.mass.gov/info-details/free-telehealth-for-covid-19-treatment-with-paxlovid#get-a-free-telehealth-consultation-", "tel:833-273-6330", "https://www.color.com/", "https://www.mass.gov/info-details/in-home-covid-19-treatment-program", "tel:617-644-7592", "https://www.patientportalma.com/s/?language=en_US", "https://www.mass.gov/info-details/information-for-providers-about-therapeutic-treatments-for-covid-19#covid-19-therapeutic-locator-", "tel:800-232-0233", "tel:888-720-7489", null, "https://aspr.hhs.gov/TestToTreat/Pages/default.aspx", "https://covid-19-test-to-treat-locator-dhhs.hub.arcgis.com/", "http://covid-19-test-to-treat-locator-dhhs.hub.arcgis.com/", null, "https://www.publichealthwm.org/covid-19/data", "https://www.publichealthwm.org/covid-19/prevention", "https://www.publichealthwm.org/covid-19/Testing-Resources", "https://www.publichealthwm.org/covid-19/vaccine", "https://www.publichealthwm.org/covid-19/vaccine/FAQ", "https://www.publichealthwm.org/covid-19/vaccine/Vaccine-Hesitancy", "https://www.publichealthwm.org/covid-19/Treatments", "https://www.publichealthwm.org/covid-19/covid-19-community-resources", "https://www.publichealthwm.org/covid-19/recursos-espanol", "https://www.publichealthwm.org/covid-19/recursos-espanol/prevencion-es", "https://www.publichealthwm.org/covid-19/recursos-espanol/Testing-Resources-es", "https://www.publichealthwm.org/covid-19/vacuna-es", "https://www.publichealthwm.org/covid-19/recursos-espanol/FAQ-es", "https://www.publichealthwm.org/covid-19/recursos-espanol/Tratamientos", "https://www.publichealthwm.org/covid-19/recursos-espanol/Vaccine-Hesitancy-es", "https://www.publichealthwm.org/covid-19/events", "https://www.publichealthwm.org/covid-19/advocacy", "https://www.facebook.com/PublicHealthMA/", "https://www.publichealthwm.org/download_file/view/4901", "https://www.publichealthwm.org/privacy-policy", "#footer-credit-popup", "https://www.wildappledesigngroup.com/", "", "https://www.publichealthwm.org/what-health-equity", "https://www.publichealthwm.org/what-health-equity/what-influences-health", "https://www.publichealthwm.org/what-health-equity/racial-equity-resources", "https://www.publichealthwm.org/what-health-equity/racial-equity-resources/organizationswebsites", "https://www.publichealthwm.org/what-health-equity/racial-equity-resources/resources", "https://www.publichealthwm.org/what-health-equity/june-14th-health-equity-event", "https://www.publichealthwm.org/who-we-are", "https://www.publichealthwm.org/who-we-are/mission", "https://www.publichealthwm.org/who-we-are/board", "https://www.publichealthwm.org/who-we-are/staff", "https://www.publichealthwm.org/who-we-are/impact", "https://www.publichealthwm.org/who-we-are/history", "https://www.publichealthwm.org/who-we-are/join-our-team", "https://www.publichealthwm.org/what-we-do", "https://www.publichealthwm.org/what-we-do/coalition-building", "https://www.publichealthwm.org/what-we-do/coalition-building/live-well-springfield", "https://www.publichealthwm.org/what-we-do/coalition-building/live-well-springfield/agefriendly", "https://www.publichealthwm.org/what-we-do/coalition-building/live-well-springfield/tci", "https://www.publichealthwm.org/what-we-do/coalition-building/pioneer-valley-asthma-coalition", "https://www.publichealthwm.org/what-we-do/coalition-building/springfield-climate-justice-initiative", "https://www.publichealthwm.org/what-we-do/coalition-building/413cares", "https://www.publichealthwm.org/what-we-do/coalition-building/chip", "https://www.publichealthwm.org/what-we-do/coalition-building/youth-mental-health", "https://www.publichealthwm.org/what-we-do/coalition-building/youth-mental-health/training", "https://www.publichealthwm.org/what-we-do/coalition-building/capacity-building-racial-equity", "https://www.publichealthwm.org/what-we-do/research-evaluation", "https://www.publichealthwm.org/what-we-do/research-evaluation/reports", "https://www.publichealthwm.org/what-we-do/research-evaluation/reports/project-accces", "https://www.publichealthwm.org/youth-health-survey-initiative", "https://www.publichealthwm.org/what-we-do/research-evaluation/reports/phc-receives-rwjf-grant-study", "https://www.publichealthwm.org/what-we-do/research-evaluation/reports/community-health-needs-assessments", "https://www.publichealthwm.org/what-we-do/research-evaluation/reports/HIA-CORI", "https://www.publichealthwm.org/what-we-do/research-evaluation/reports/COVID-Impact-TA", "https://www.publichealthwm.org/what-we-do/research-evaluation/reports/western-massachusetts-casino-health-impact-assessment", "https://www.publichealthwm.org/what-we-do/research-evaluation/reports/western-massachusetts-casino-health-impact-assessment/community-priorities", "https://www.publichealthwm.org/what-we-do/research-evaluation/reports/western-massachusetts-casino-health-impact-assessment/committee-structure", "https://www.publichealthwm.org/what-we-do/research-evaluation/reports/western-massachusetts-casino-health-impact-assessment/casino-hia-frequently-asked-questions", "https://www.publichealthwm.org/what-we-do/research-evaluation/reports/western-massachusetts-casino-health-impact-assessment/media-coverage", "https://www.publichealthwm.org/what-we-do/research-evaluation/reports/western-massachusetts-casino-health-impact-assessment/casino-licensing-timeline", "https://www.publichealthwm.org/what-we-do/research-evaluation/reports/western-massachusetts-casino-health-impact-assessment/casino-health-impact-assessment-timeline", "https://www.publichealthwm.org/what-we-do/research-evaluation/reports/culturerx-findings-berkshires-springfield", "https://www.publichealthwm.org/what-we-do/research-evaluation/reports/Violence-Against-Girls", "https://www.publichealthwm.org/policy", "https://www.publichealthwm.org/what-we-do/data-reports", "https://www.publichealthwm.org/what-we-do/data-reports/other-data-and-resources", "https://www.publichealthwm.org/news-events", "https://www.publichealthwm.org/contact-us", "https://www.publichealthwm.org/covid-19", "https://www.publichealthwm.org/covid-19/data", "https://www.publichealthwm.org/covid-19/prevention", "https://www.publichealthwm.org/covid-19/Testing-Resources", "https://www.publichealthwm.org/covid-19/vaccine", "https://www.publichealthwm.org/covid-19/vaccine/FAQ", "https://www.publichealthwm.org/covid-19/vaccine/Vaccine-Hesitancy", "https://www.publichealthwm.org/covid-19/Treatments", "https://www.publichealthwm.org/covid-19/covid-19-community-resources", "https://www.publichealthwm.org/covid-19/recursos-espanol", "https://www.publichealthwm.org/covid-19/recursos-espanol/prevencion-es", "https://www.publichealthwm.org/covid-19/recursos-espanol/Testing-Resources-es", "https://www.publichealthwm.org/covid-19/vacuna-es", "https://www.publichealthwm.org/covid-19/recursos-espanol/FAQ-es", "https://www.publichealthwm.org/covid-19/recursos-espanol/Tratamientos", "https://www.publichealthwm.org/covid-19/recursos-espanol/Vaccine-Hesitancy-es", "https://www.publichealthwm.org/covid-19/events", "https://www.publichealthwm.org/covid-19/advocacy"]}